In endometrial cancer, IL-10 has been shown to promote epithelial–mesenchymal transition (EMT) and vascular mimicry, which are processes associated with tumor progression, suggesting a possible role in assessing tumor aggressiveness and patient outcomes [31]. This evidence concerns the gene IL10 and endometrial cancer.